These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 8750064

  • 21. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.
    Buduneli N, Buduneli E, Ciotanar S, Atilla G, Lappin D, Kinane D.
    J Clin Periodontol; 2004 Jul; 31(7):556-61. PubMed ID: 15191592
    [Abstract] [Full Text] [Related]

  • 22. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J, Delarue F, Peraldi MN, Sraer JD, Rondeau E.
    Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
    [Abstract] [Full Text] [Related]

  • 23. Possible role of the plasminogen activation system in human subfertility.
    Ebisch IM, Steegers-Theunissen RP, Sweep FC, Zielhuis GA, Geurts-Moespot A, Thomas CM.
    Fertil Steril; 2007 Mar; 87(3):619-26. PubMed ID: 17123524
    [Abstract] [Full Text] [Related]

  • 24. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
    Koh SC, Yuen R, Viegas OA, Chua SE, Ng BL, Sen DK, Ratnam SS.
    Thromb Haemost; 1991 Nov 01; 66(5):581-5. PubMed ID: 1803623
    [Abstract] [Full Text] [Related]

  • 25. [Tissue plasminogen activator and plasminogen activator inhibitor in aqueous humor].
    Giedrojć J, Stankiewicz A, Walkowiak M, Galar M, Bielawiec M.
    Klin Oczna; 1996 Nov 01; 98(4):283-5. PubMed ID: 9463119
    [Abstract] [Full Text] [Related]

  • 26. Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma.
    Hofmann R, Lehmer A, Buresch M, Hartung R, Ulm K.
    Cancer; 1996 Aug 01; 78(3):487-92. PubMed ID: 8697395
    [Abstract] [Full Text] [Related]

  • 27. Tissue-type plasminogen activator in the chronic subdural hematoma.
    Ito H, Saito K, Yamamoto S, Hasegawa T.
    Surg Neurol; 1988 Sep 01; 30(3):175-9. PubMed ID: 3137677
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
    Zalewska-Rydzkowska D, Rość D, Ponikowska I, Michalski A, Graczykowska-Koczorowska A, Rydzkowski M.
    Pol Merkur Lekarski; 2001 Nov 01; 11(65):414-7. PubMed ID: 11852811
    [Abstract] [Full Text] [Related]

  • 30. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease.
    Pedersen OD, Gram J, Jespersen J.
    Thromb Haemost; 1995 May 01; 73(5):835-40. PubMed ID: 7482412
    [Abstract] [Full Text] [Related]

  • 31. Plasminogen activator and plasminogen activator inhibitor in human preovulatory follicular fluid.
    Jones PB, Vernon MW, Muse KN, Curry TE.
    J Clin Endocrinol Metab; 1989 Jun 01; 68(6):1039-45. PubMed ID: 2470770
    [Abstract] [Full Text] [Related]

  • 32. Short term effects of non-surgical periodontal treatment on gingival crevicular fluid levels of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2 (PAI-2) in patients with chronic and aggressive periodontitis.
    Tüter G, Ozdemir B, Kurtiş B, Serdar M, Yücel AA, Ayhan E.
    Arch Oral Biol; 2013 Apr 01; 58(4):391-6. PubMed ID: 22980426
    [Abstract] [Full Text] [Related]

  • 33. Plasminogen activator: the identification of an additional proteinase at the outer acrosomal membrane of human and boar spermatozoa.
    Smokovitis A, Kokolis N, Taitzoglou I, Rekkas C.
    Int J Fertil; 1992 Apr 01; 37(5):308-14. PubMed ID: 1358844
    [Abstract] [Full Text] [Related]

  • 34. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb 01; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 35. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.
    Med Sci Monit; 2000 Feb 01; 6(4):684-91. PubMed ID: 11208392
    [Abstract] [Full Text] [Related]

  • 36. A specific immunologic assay for functional plasminogen activator inhibitor 1 in plasma--standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic disease.
    Philips M, Juul AG, Selmer J, Lind B, Thorsen S.
    Thromb Haemost; 1992 Nov 10; 68(5):486-94. PubMed ID: 1455392
    [Abstract] [Full Text] [Related]

  • 37. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC.
    Thromb Res; 2008 Nov 10; 121(5):675-80. PubMed ID: 17870147
    [Abstract] [Full Text] [Related]

  • 38. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
    Cederqvist K, Sirén V, Petäjä J, Vaheri A, Haglund C, Andersson S.
    Pediatrics; 2006 Apr 10; 117(4):1226-34. PubMed ID: 16585319
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Complex congenital malformations and the impact of the plasminogen activator system and beta-hCG in amniotic fluid.
    Verkleij-Hagoort AC, Ursem NT, Hop WC, Geurts-Moespot A, Steegers EA, Sweep FC, Steegers-Theunissen RP.
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov 10; 135(1):47-52. PubMed ID: 17141398
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.